LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
University of Pittsburgh
Pittsburgh, Estados UnidosPublications in collaboration with researchers from University of Pittsburgh (3)
2016
-
1320_PR: Subgroup analyses of patients with epidermal growth factor receptor (EGFR)-expressing tumors in SQUIRE: A randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin (GC) plus necitumumab (N) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC)
Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S153
-
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: A randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer
Annals of Oncology, Vol. 27, Núm. 8, pp. 1573-1579